Thinking continuously: a microreactor for the production and scale-up of biodegradable, self-assembled nanoparticles

Scale-up of nanoparticle batch productions continues to be a major challenge in the pharmaceutical nanotechnology. Continuously operating microreactors have great potential to circumvent the scale-up difficulties. In this work a passive microreactor was used for the first time for the electrostatic self-assembly of biodegradable, mucoadhesive thiomer–protamine nanoparticles for drug delivery. The influence of three different parameters (the overall flow rate, the educt mass ratio and the molecular weight of the thiomer) on the particle characteristics was tested for the microreactor production and compared to the results of a successful 1 ml-batch reaction. As the flow rate increased (2, 5, 9, 16 ml min−1), the particle sizes and the polydispersity indexes decreased. In addition, the protamine : 5 kDa thiomer binding ratio and hence the zeta potential, as a measure of the suspension's stability, increased to >+40 mV due to better mixing during the microreactor production at a flow rate of 16 ml min−1. Producing nanoparticles from different mass ratios of 5 kDa thiomer : protamine (1 : 1, 1 : 3, 1 : 5) in the microreactor at this flow rate resulted in smaller particles with more distinct zeta potentials than those prepared by the 1 ml-batch reaction. Using a higher molecular weight thiomer (30 kDa) for the microreactor production at a flow rate of 16 ml min−1 led to slightly increased mean particle sizes (125.0 nm) compared to those produced by the 1 ml-batch reaction (102.9 nm). However, there was still a decrease in the width of the particle size distributions. In addition to the experimental work, a numerical model based on the population balance equation was developed. The results presented in this paper are in agreement with the experimental findings, especially with regard to the trends of decreased particle size and polydispersity with the increasing flow rate. The model results confirm that mixing effects to a great extent determine the particle size distribution of the resulting nanoparticles and show that spatial inhomogeneity of the mixing process must be taken into account. The unprecedented use of a passive microreactor for the production of biodegradable thiomer–protamine nanoparticles by electrostatic self-assembly was a success. Due to the reactor's continuous way of operation, not only were the scale-up problems of batch reactions overcome, but particle characteristics were also improved because of a better mixing effect.

[1]  Chih-Hung Chang,et al.  Synthesis and post-processing of nanomaterials using microreaction technology , 2008 .

[2]  A. Zimmer,et al.  Modeling and simulation of polyacrylic acid/protamine nanoparticle precipitation , 2011 .

[3]  A. R. Kulkarni,et al.  Biodegradable polymeric nanoparticles as drug delivery devices. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[4]  D. Bothe,et al.  Fluid mixing in a T-shaped micro-mixer , 2006 .

[5]  J. Kreuter,et al.  Colloidal Drug Delivery Systems , 1994 .

[6]  Anton P. J. Middelberg,et al.  Nanoparticle synthesis in microreactors , 2011 .

[7]  A. Bernkop‐Schnürch,et al.  Mucoadhesive and cohesive properties of poly(acrylic acid)-cysteine conjugates with regard to their molecular mass. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[8]  Antonello Barresi,et al.  CFD modelling and scale-up of Confined Impinging Jet Reactors , 2007 .

[9]  R. Tan,et al.  Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. , 2011, International journal of pharmaceutics.

[10]  Bartosz A Grzybowski,et al.  Microfluidic mixers: from microfabricated to self-assembling devices , 2004, Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences.

[11]  Hatem Fessi,et al.  Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[12]  A. Zimmer,et al.  Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Junxian Yun,et al.  Formation of solid lipid nanoparticles in a microchannel system with a cross-shaped junction , 2008 .

[14]  Paul Watts,et al.  Recent advances in micro reaction technology. , 2011, Chemical communications.

[15]  Lei Shao,et al.  Microfluidic Fabrication of Monodispersed Pharmaceutical Colloidal Spheres of Atorvastatin Calcium with Tunable Sizes , 2010 .

[16]  Swarnlata Saraf,et al.  Nanocarriers: promising vehicle for bioactive drugs. , 2006, Biological & pharmaceutical bulletin.

[17]  A. Zimmer,et al.  New protamine quantification method in microtiter plates using o-phthaldialdehyde/N-acetyl-L-cysteine reagent. , 2004, International journal of pharmaceutics.

[18]  R. Müller,et al.  Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.

[19]  A. Bernkop‐Schnürch Thiomers: a new generation of mucoadhesive polymers. , 2005, Advanced drug delivery reviews.

[20]  J. Hanes,et al.  Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. , 2009, Advanced drug delivery reviews.

[21]  Peter York,et al.  Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. , 2009, International journal of pharmaceutics.

[22]  J. Köhler,et al.  Continuous synthesis of gold nanoparticles in a microreactor. , 2005, Nano letters.

[23]  V. Hessel,et al.  Micromixers—a review on passive and active mixing principles , 2005 .

[24]  Robert Langer,et al.  Microfluidic platform for controlled synthesis of polymeric nanoparticles. , 2008, Nano letters.

[25]  A. Zimmer,et al.  Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: physicochemical characterization. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  J. Winther,et al.  Quantification of protein thiols and dithiols in the picomolar range using sodium borohydride and 4,4'-dithiodipyridine. , 2007, Analytical biochemistry.

[27]  Andrew deMello,et al.  Microscale reactors: nanoscale products. , 2004, Lab on a chip.

[28]  A. Zimmer,et al.  Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Junxian Yun,et al.  Preparation of solid lipid nanoparticles in co-flowing microchannels , 2008 .

[30]  N. Ochekpe,et al.  Nanotechnology and Drug Delivery Part 1: Background and Applications , 2009 .

[31]  Andrew D Griffiths,et al.  Droplet-based microreactors for the synthesis of magnetic iron oxide nanoparticles. , 2008, Angewandte Chemie.

[32]  Lei Shao,et al.  Microfluidic synthesis of amorphous cefuroxime axetil nanoparticles with size-dependent and enhanced dissolution rate , 2010 .

[33]  Wolfgang Peukert,et al.  Combined experimental/numerical study on the precipitation of nanoparticles , 2004 .

[34]  I. Molnár-Perl,et al.  Stability and characteristics of the o-phthaldialdehyde/3-mercaptopropionic acid and o-phthaldialdehyde/ N-acetyl- l-cysteine reagents and their amino acid derivatives measured by high-performance liquid chromatography 1 Presented at the 22nd International Symposium on High-Performance Liquid Phase , 1999 .

[35]  C. Sönnichsen,et al.  Microfluidic continuous flow synthesis of rod-shaped gold and silver nanocrystals. , 2006, Physical Chemistry, Chemical Physics - PCCP.

[36]  Dwight W. Chasar,et al.  STANDING COMMITTEESS: DIVISIONAL ACTIVITIES , 2005 .

[37]  V. Lamer,et al.  Theory, Production and Mechanism of Formation of Monodispersed Hydrosols , 1950 .

[38]  Yuchao Zhao,et al.  A high throughput methodology for continuous preparation of monodispersed nanocrystals in microfluidic reactors , 2008 .

[39]  Junxian Yun,et al.  Continuous production of solid lipid nanoparticles by liquid flow-focusing and gas displacing method in microchannels , 2009 .

[40]  Justin J Cooper-White,et al.  Biopolymer microparticle and nanoparticle formation within a microfluidic device. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[41]  B. Mishra,et al.  Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[42]  M. Haaf,et al.  Solving the clogging problem: precipitate-forming reactions in flow. , 2006, Angewandte Chemie.

[43]  B. Prasad,et al.  Continuous flow synthesis of functionalized silver nanoparticles using bifunctional biosurfactants , 2010 .

[44]  J. A. Hoffmann,et al.  Purification and analysis of the major components of chum salmon protamine contained in insulin formulations using high-performance liquid chromatography. , 1990, Protein expression and purification.

[45]  Uday B. Kompella,et al.  Nanoparticle technology for drug delivery , 2006 .

[46]  Ann M. Thayer,et al.  HARNESSING MICROREACTIONS: Researchers find that processes run in microreactors open doors to more efficient and novel chemistry useful for fine chemicals and intermediates , 2005 .

[47]  Josef Hormes,et al.  Microfluidic synthesis of nanomaterials. , 2008, Small.

[48]  Jianfeng Chen,et al.  Preparation of Drug Nanoparticles Using a T-Junction Microchannel System , 2011 .